Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|NEO-201||NEO 201|NEO201|h16C3||NEO-201 is a monoclonal antibody that binds to tumor antigens, potentially including CEACAM family members, which may result in enhanced anti-tumor antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity (PMID: 29354121, PMID: 32637350).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|
|NCT03476681||Phase I||NEO-201||QUILT-3.017: Study of NEO-201 in Solid Tumors||Recruiting||USA||0|